Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma

Renal medullary carcinoma (RMC) is one of the most aggressive renal cell carcinomas. It predominantly afflicts young adults and adolescents with sickle cell trait and other sickle hemoglobinopathies, and is refractory to targeted and anti-angiogenic therapies used in patients with clear-cell renal c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Genitourin Cancer
Autors principals: Msaouel, Pavlos, Hong, Andrew L., Mullen, Elizabeth A., Atkins, Michael B., Walker, Cheryl Lyn, Lee, Chung-Han, Carden, Marcus A., Genovese, Giannicola, Linehan, W. Marston, Rao, Priya, Merino, Maria J., Grodman, Howard, Dome, Jeffrey S., Fernandez, Conrad V., Geller, James I., Apolo, Andrea B., Daw, Najat C., Hodges, H. Courtney, Moxey-Mims, Marva, Wei, Darmood, Bottaro, Donald P., Staehler, Michael, Karam, Jose A., Rathmell, W. Kimryn, Tannir, Nizar M.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348017/
https://ncbi.nlm.nih.gov/pubmed/30287223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2018.09.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars